Armstrong J, Pfister D, Strong E, Heimann R, Kraus D, Polishook A, Zelefsky M, Bosl G, Shah J, Spiro R
Department of Radiation Oncology, Brachytherapy Service, Memorial Sloan-Kettering Cancer Center, NYC, NY 10021.
Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):759-65. doi: 10.1016/0360-3016(93)90489-i.
For patients with squamous cell carcinoma of the head and neck with palpable neck node metastases, the standard management of the neck usually involves neck dissection and postoperative neck irradiation. A strategy of larynx preservation with induction chemotherapy and radiation therapy has been utilized for patients with locally advanced resectable cancer of the larynx, hypopharynx, and oropharynx. For patients treated in this non-surgical manner for the primary site, the optimal management of the clinically positive neck has not been clarified. To determine whether response to induction chemotherapy could help to select patients in whom neck dissection could be omitted in favor of definitive radiation therapy alone, we have analyzed our prospective larynx preservation experience.
Between 1983-1989, 80 patients were entered onto larynx preservation protocols involving 1-3 cycles of cisplatin based chemotherapy followed by radiation therapy with or without neck dissection. There were 54 patients with clinically positive necks to treatment, of whom 44% (24/54) had a complete response, and of whom 20% (11/54) had a partial response to chemotherapy in the neck. In 22 of these 35 patients with clinically positive necks who achieved a major neck response to chemotherapy, radiation therapy (median 66 Gy) was used as the only subsequent treatment of the neck.
At a median follow-up of 25 months (range 7-83 months), neck control for this subset is 91% (20/22). Neck failure occurred in 20% (1/5) of patients with a partial response to chemotherapy treated without neck dissection and 6% (1/17) of node positive with a complete response.
These results suggest that patients with clinically palpable cervical nodal metastases who have a complete response to chemotherapy and receive high dose radiation therapy have excellent neck control and may not need neck dissection. Further experience will be required to confirm these preliminary data and to determine if patients who achieve a partial response in the neck after induction chemotherapy can be treated with radiation therapy without neck dissection.
对于头颈部鳞状细胞癌且可触及颈部淋巴结转移的患者,颈部的标准治疗通常包括颈部清扫术及术后颈部放疗。对于局部晚期可切除的喉癌、下咽癌及口咽癌患者,已采用诱导化疗和放疗的保喉策略。对于以这种非手术方式治疗原发部位的患者,临床上阳性颈部的最佳治疗方法尚未明确。为了确定诱导化疗的反应是否有助于选择可省略颈部清扫术而仅采用根治性放疗的患者,我们分析了我们的前瞻性保喉经验。
1983年至1989年间,80例患者进入保喉方案,接受1 - 3周期以顺铂为基础的化疗,随后进行放疗,部分患者进行或不进行颈部清扫术。有54例患者颈部治疗时临床上呈阳性,其中44%(24/54)完全缓解,20%(11/54)颈部化疗部分缓解。在这35例颈部临床上呈阳性且对化疗有主要颈部反应的患者中,22例患者后续颈部仅采用放疗(中位剂量66 Gy)。
中位随访25个月(范围7 - 83个月),该亚组的颈部控制率为91%(20/22)。未进行颈部清扫术治疗的化疗部分缓解患者中,20%(1/5)出现颈部复发;完全缓解的淋巴结阳性患者中,6%(1/17)出现颈部复发。
这些结果表明,临床上可触及颈部淋巴结转移且对化疗完全缓解并接受高剂量放疗的患者,颈部控制良好,可能无需进行颈部清扫术。需要进一步的经验来证实这些初步数据,并确定诱导化疗后颈部部分缓解的患者是否可以仅用放疗而不进行颈部清扫术治疗。